Gain-of-function mutations in NLRP3 lead to constitutive inflammasome activation and excessive IL-1β production and are associated with the development of cryopyrin-associated periodic syndrome (CAPS) [255]. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.